Wesley Yon is an Analyst at Catalio Capital Management, LP.
He is currently a Ph.D. candidate at the Cell, Molecular, Development Biology, and Biophysics program at Johns Hopkins University. His research utilizes single-molecule biophysical, biochemical, and microscopy techniques to study protein condensation and how this process regulates cellular division. Previously, he worked at the Icahn School of Medicine at Mount Sinai Hospital, where he focused on developing a personalized therapeutics platform to discover novel treatments cancer patients.
Wesley earned a B.S. in Cell and Developmental Biology from the University of Rochester.